Spironolactone Patent Expiration
Spironolactone is Used for managing edema in cirrhotic patients and treating heart failure with reduced ejection fraction to increase survival and reduce hospitalizations. It was first introduced by Pfizer Inc
Spironolactone Patents
Given below is the list of patents protecting Spironolactone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Carospir | US10493083 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10624906 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10660907 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US10888570 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11389461 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11395828 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US11491166 | Spironolactone aqueous compositions | Oct 28, 2036 | Cmp Dev Llc |
| Carospir | US9757394 | Spironolactone aqueous formulations | Oct 28, 2036 | Cmp Dev Llc |
Spironolactone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List